Ten-Year Clinical Experience with the Lumenless, Catheter-Delivered, 4.1-Fr Diameter Pacing Lead in Patients with and without Congenital Heart
Autor: | Sharmeen Samuel, Kathleen Zelin, Neha Bansal, Peter P. Karpawich |
---|---|
Rok vydání: | 2017 |
Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment Retrospective cohort study General Medicine 030204 cardiovascular system & hematology 03 medical and health sciences Catheter 0302 clinical medicine medicine.anatomical_structure Ventricle Internal medicine medicine Cardiology In patient 030212 general & internal medicine Implant Young adult Cardiology and Cardiovascular Medicine business Lead (electronics) Cardiac catheterization |
Zdroj: | Pacing and Clinical Electrophysiology. 40:17-25 |
ISSN: | 0147-8389 |
DOI: | 10.1111/pace.12995 |
Popis: | BACKGROUND Patients with congenital heart defects (CHD) often present more challenges to pacing therapy due to anatomy than those without CHD. The lumenless, 4.1Fr diameter M3830 pacing lead (Medtronic, Inc., Minneapolis, MN, USA), approved for use in 2005, has, to date, reported to have excellent short-term ( |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |